Related references
Note: Only part of the references are listed.Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015
Robert M. R. Tulloh et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2019)
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial
Hiromichi Hamada et al.
LANCET (2019)
Improving coronary artery outcomes for children with Kawasaki disease
Brian W. McCrindle et al.
LANCET (2019)
Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016
Nobuko Makino et al.
PEDIATRICS INTERNATIONAL (2019)
European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative
Seza Ozen et al.
RHEUMATOLOGY (2019)
Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne
Marion de La Harpe et al.
FRONTIERS IN PEDIATRICS (2019)
European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative
Nienke de Graeff et al.
RHEUMATOLOGY (2019)
European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative
Nienke de Graeff et al.
RHEUMATOLOGY (2019)
A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience
Melanie Rama et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2018)
Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment
Isabelle Meyts et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2018)
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
Gina A. Montealegre Sanchez et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Genetic testing for DADA2: How can we avoid missing patients?
Hafize Emine Sonmez et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2018)
Vasculitis in Systemic Autoinflammatory Diseases
Selcan Demir et al.
FRONTIERS IN PEDIATRICS (2018)
The Epidemiology and Pathogenesis of Kawasaki Disease
Anne H. Rowley et al.
FRONTIERS IN PEDIATRICS (2018)
Clinical Presentation and Cardiovascular Outcome in Complete versus Incomplete Kawasaki Disease
G. Shivalingam et al.
INDIAN PEDIATRICS (2017)
The changing face of polyarteritis nodosa and necrotizing vasculitis
Seza Ozen
NATURE REVIEWS RHEUMATOLOGY (2017)
Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: a population-based study
Maryam Piram et al.
RHEUMATOLOGY (2017)
Screening of 181 Patients With Antibody Deficiency for Deficiency of Adenosine Deaminase 2 Sheds New Light on the Disease in Adulthood
Johanna Schepp et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Childhood systemic vasculitis
Erdal Sag et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2017)
ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study
Roberta Caorsi et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease A Scientific Statement for Health Professionals From the American Heart Association
Brian W. McCrindle et al.
CIRCULATION (2017)
Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy
Justin Chia et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis Nodosa
Lisa V. Hampson et al.
PLOS ONE (2015)
Early- Onset Stroke and Vasculopathy Associated with Mutations in ADA2
Qing Zhou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Activated STING in a Vascular and Pulmonary Syndrome
Y. Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein Purpura (HSP)
Jan Dudley et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2013)
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
J. C. Jennette et al.
ARTHRITIS AND RHEUMATISM (2013)
Systemic Polyarteritis Nodosa in the Young: A Single-Center Experience Over Thirty-Two Years
Despina Eleftheriou et al.
ARTHRITIS AND RHEUMATISM (2013)
EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria
Seza Ozen et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Early prednisone therapy in Henoch-Schonlein purpura:: A randomized, double-blind, placebo-controlled trial
Jaana Ronkainen et al.
JOURNAL OF PEDIATRICS (2006)
Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease
Tohru Kobayashi et al.
CIRCULATION (2006)
Henoch schonlein purpura in childhood: Epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature
S Trapani et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Juvenile polyarteritis:: Results of a multicenter survey of 110 children
S Ozen et al.
JOURNAL OF PEDIATRICS (2004)
TAP deficiency syndrome
SD Gadola et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Share Paper
